Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.

As with the intravenous form, subcutaneous anifrolumab shows clinically meaningful benefits and favorable safety when added ...

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...

Johnson & Johnson has claimed FDA approval for Rybrevant Faspro, a subcutaneous version of its EGFRxMET bispecific antibody, for all the indications approved for the current, intravenous formulation.

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.

Here’s what the science says.

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that its Phase Ib/II study of ...

AstraZeneca (NASDAQ:AZN) is one of the best future stocks to buy for the long term. On January 6, Barclays analyst James Gordon raised the firm’s price target on AstraZeneca to 16,500 GBp from 14,000 ...

Mounjaro (tirzepatide) is a prescription medication used with diet and exercise to help adults with type 2 diabetes manage blood sugar levels. Mounjaro comes as an injection given under the skin.